Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Half-Dose Intracoronary Abciximab in PCI
NCT00320229Phase 4Terminated
- Start
- Dec 2004
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of abciximab in myocardial infarction (MI), unstable angina. Started Dec 2004; status: terminated.
02
Drugs
abciximab
03
Conditions
myocardial infarction (MI)unstable angina
Beyond the preview
Go deeper on NCT00320229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320229.